Laptaria cu Caimac has completed an IPO
Laptaria cu Caimac has raised US$5 million through a private placement of shares on the ATS Market of BSE. The funds will be used for the development of the factory, namely, the construction of a bottle and jar washing station, utility systems and packaging storage.
Laptaria cu Caimac was established in 1994 and was initially focused on agricultural activities, large crops (wheat, barley, rapeseed, triticale, corn, alfalfa and others, on an area of 3,000 ha, and a dairy farm (with over 2,700 animals). In 2018, it opened a modern dairy factory and launched Laptaria cu Caimac, a brand that has experienced rapid growth in popularity due to its high quality products. Laptaria cu Caimac has its own farm and uses the latest means to produce quality, natural, safe, nutritious dairy products without unnecessary additives. The modern processing plant has a technical processing capacity of around 75 tonnes of milk per day, and modern processing techniques that allow milk to be pasteurized at a lower-than-average temperature.
Oaklins’ team in Romania, in its role as authorized consultant, assisted Laptaria cu Caimac’s management team and shareholders all the way, from the start to the successful completion of the IPO. During this process, the team initiated and advised on many aspects, including, among others, securing cornerstone investors, deal structuring and the IPO pricing and sizing.
CEO, Laptaria cu Caimac
Talk to the deal team
Managing DirectorBucharest, Romania
Oaklins BT Capital
Serban Cristian Dumitrescu
Oaklins BT Capital
Bigtincan (ASX:BTH) has raised capital to fund the acquisition of Brainshark Inc.
Bigtincan Holdings Limited (ASX:BTH) has raised US$98.6 via a placement and underwritten accelerated non-renounceable entitlement offer.Learn more
Alice Queen (ASX:AQX) has raised funds via an institutional placement
Alice Queen Limited (ASX:AQX) has completed a fundraising. The funds will be used to complete the Horn Island Scoping Study, accelerate exploration activities at Horn Island and support working capital. The placement was significantly oversubscribed and strongly supported by a major shareholder, as well as several existing shareholders and new institutional and sophisticated investors.Learn more
Poolbeg Pharma has completed an Initial Public Offering on AIM
Poolbeg Pharma Plc has raised funds to develop the company.Learn more